Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome. (Q54236665)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome. (English)

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

1 reference

based on heuristic

inferred from title

author name string

Ying-Ying Zhang

1

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

Xin Zhou

2

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

Wen-Jie Ji

3

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

Rui Shi

4

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

Rui-Yi Lu

5

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

Jin-Long Li

6

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

Guo-Hong Yang

7

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

Tao Luo

8

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

Jian-Qi Zhang

9

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

Ji-Hong Zhao

10

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

Tie-Min Jiang

11

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

Yu-Ming Li

12

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

publication date

1 July 2014

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

Journal of Thrombosis and Thrombolysis

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

38

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

65-72

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

1

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

https://scigraph.springernature.com/pub.10.1007/s11239-013-1022-9

0 references

2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiol

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

ACCF/AHA Clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Cytochrome p-450 polymorphisms and response to clopidogrel

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Calcium-channel blockers reduce the antiplatelet effect of clopidogrel

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Clopidogrel and proton pump inhibitors: influence of pharmacological interactions on clinical outcomes and mechanistic explanations

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Smoking, clopidogrel, and mortality in patients with established cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

MicroRNAs: target recognition and regulatory functions

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Existence of a microRNA pathway in anucleate platelets

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Prospective study on circulating MicroRNAs and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Circulating microRNAs as novel biomarkers for platelet activation.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Platelet microRNAs: Novy Mir* or mired in human complexity?

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Intercellular transport of microRNAs

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Microparticles: major transport vehicles for distinct microRNAs in circulation

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Macrophage microvesicles induce macrophage differentiation and miR-223 transfer

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

MicroRNA function in myeloid biology

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

NLRP3 inflammasome activity is negatively controlled by miR-223.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

MiR-223 suppresses cell proliferation by targeting IGF-1R.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Thrombosis as an intravascular effector of innate immunity

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Association of cytochrome P450 2C19*2 polymorphism with clopidogrel response variability and cardiovascular events in Koreans treated with drug-eluting stents.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS11239-013-1022-9

21 January 2018

Decreased platelet miR-223 expression is associated with high on-clopidogrel platelet reactivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

microRNA-223 promotes the growth and invasion of glioblastoma cells by targeting tumor suppressor PAX6.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of CYP2C19*2 and *3 loss-of-function alleles on platelet reactivity and adverse clinical events in East Asian acute myocardial infarction survivors treated with clopidogrel and aspirin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11239-013-1022-9

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/24202700

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54236665&oldid=1420135520"